Lung Cancer Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People aged 18 or older, of any gender.
- People who have been diagnosed with peripheral lung cancer, where the largest tumor is no bigger than 3 cm across and there are no more than 3 tumors in total.
- People whose tumor(s) have been assessed by doctors as suitable for a bronchoscope-guided freezing treatment (a procedure that uses a thin tube passed into the airways to freeze and destroy the tumor).
- People who have refused or been found unsuitable for radiation or chemotherapy, or whose cancer did not respond to previous radiation or chemotherapy, or whose cancer got worse after radiation or chemotherapy.
- People who have been assessed as not suitable for surgery, or who have chosen not to have surgery or radiation therapy, who agree to receive the freezing treatment as their first treatment, and who have signed a consent form agreeing to take part.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who have widespread spots throughout both lungs where the freezing treatment is unlikely to help.
- People whose tests in the month before the procedure show that the cancer has spread to nearby lymph nodes near the lung's main airway, or to other parts of the body outside the lungs (unless that spread outside the lungs has already been successfully treated locally).
- People who have medical reasons why a bronchoscopy (a camera procedure through the airways) cannot be done safely, or who are unable to tolerate or cooperate with the procedure.
- People with a serious tendency to bleed or a blood-clotting problem that cannot be corrected (confirmed by specific blood test results being outside acceptable ranges).
- People whose platelet count (a measure of clotting cells in the blood) is too low, or who have not stopped taking blood-thinning or anti-clotting medicines for more than one week before the procedure (with an exception for a specific type of preventive blood-thinning injection given before the operation).
- People with severely reduced lung function, where the lungs are working at less than 40% of their expected maximum breathing capacity.
- People who also have another cancer with widespread spread throughout the body and whose doctors estimate they have less than 3 months to live.
- People in poor overall health, including those with cancer spread throughout the body, severe infection, high fever, infection or radiation-related inflammation around the tumor, significant wasting of the body, severe failure of vital organs, or severe anaemia and nutritional problems that cannot be improved quickly.
- People who score higher than 2 on a standard medical scale used to measure how much a person's illness affects their ability to carry out daily activities (confirm with trial site).
- People whose tumor to be treated received radiation therapy within the past 6 months.
- People with active hepatitis B, active hepatitis C, a known history of HIV infection, or other active infections that the trial doctor considers may affect treatment.
- People with epilepsy, a history of mental illness, or problems with thinking and memory.
- Women who are pregnant or breastfeeding, and any person (male or female) planning to conceive a child during the trial period.
- People who have taken part in another clinical trial within 3 months before signing the consent form (observational studies without any treatment intervention may be an exception).
- People whom the trial doctor considers unsuitable for any other reason.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 020-81566640
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.
Primary endpoints
Adverse events incidence
Can't join this trial?
Data last synced from ClinicalTrials.gov: 17 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.